Lifting limits: liposomal delivery of chemotherapy for secondary AML with CPX-351 VJHemOnc – Video Journal of Hematology & HemOnc 2:41 6 years ago 110 Далее Скачать
What are the next steps for liposomal chemotherapy delivery and CPX-351? VJHemOnc – Video Journal of Hematology & HemOnc 2:25 6 years ago 113 Далее Скачать
Liposomal chemotherapy CPX-351: safety profile VJHemOnc – Video Journal of Hematology & HemOnc 1:04 6 years ago 108 Далее Скачать
CPX-351: Liposomal Cytarabine/Daunorubicin in Secondary AML Targeted Oncology 4:13 5 years ago 264 Далее Скачать
CPX-351: liposomal daunorubicin/cytarabine for AML VJHemOnc – Video Journal of Hematology & HemOnc 4:16 4 years ago 328 Далее Скачать
CPX-351 for secondary AML: pharmacokinetics, administration & impact on treatment VJHemOnc – Video Journal of Hematology & HemOnc 3:48 5 years ago 169 Далее Скачать
CPX-351: liposomal daunorubicin and cytarabine for treating high-risk AML VJHemOnc – Video Journal of Hematology & HemOnc 2:14 6 years ago 651 Далее Скачать
Liposomal Daunorubicin/Cytarabine for Treatment Naïve AML-MRC and t-AML MedEdOTG 9:51 5 years ago 163 Далее Скачать
CPX-351 liposome injection vs standard cytarabine and daunorubicin for older high-risk AML patients VJHemOnc – Video Journal of Hematology & HemOnc 6:16 7 years ago 715 Далее Скачать
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults... International Academy for Clinical Hematology IACH 35:36 3 years ago 250 Далее Скачать
Regulatory approval of CPX-351 for secondary AML VJHemOnc – Video Journal of Hematology & HemOnc 2:11 6 years ago 127 Далее Скачать
Cardiotoxicity of CPX-351 vs 7+3 chemotherapy in patients with untreated high-risk AML VJHemOnc – Video Journal of Hematology & HemOnc 1:55 1 year ago 127 Далее Скачать
The promise of CPX-351 in secondary AML VJHemOnc – Video Journal of Hematology & HemOnc 0:36 4 months ago 66 Далее Скачать
Intensive chemotherapy: why the modern approach of CPX-351 is important for cure in AML VJHemOnc – Video Journal of Hematology & HemOnc 3:11 2 years ago 477 Далее Скачать
Improved understanding of CPX-351 in AML: impact of HCT & final EAP results VJHemOnc – Video Journal of Hematology & HemOnc 3:07 5 years ago 178 Далее Скачать
Outcomes of patients with de-novo vs secondary AML treated with CPX-351 VJHemOnc – Video Journal of Hematology & HemOnc 2:30 2 years ago 205 Далее Скачать
